ctrl K

Price Alert

Turning Point Therapeutic... (TPTX)

NASDAQ: TPTX · Real-Time Price · USD

75.49

0.09 (0.12%)

At close: Aug 15, 2022, 10:00 PM

Turning Point Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	119K	429K	25.2K	460K	5.16M	25.2M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	119K	429K	25.2K	460K	5.16M	25.2M
Operating Income	-123.09M	-74.44M	-78.45M	-66.65M	-56.66M	-36.05M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-123.09M	-74.44M	-78.45M	-66.33M	-56.27M	-35.5M
Net Income	-123.09M	-74.44M	-78.45M	-66.33M	-56.27M	-35.5M
Selling & General & Admin	37.7M	20.31M	20.46M	18.22M	17.17M	19.99M
Research & Development	86.79M	55.05M	58.18M	48.89M	44.65M	41.26M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	124.48M	75.36M	78.64M	67.11M	61.82M	61.25M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	124.48M	75.36M	78.64M	67.11M	61.82M	61.25M
Income Tax Expense	1.28M	490K	192K	328K	384K	n/a
Shares Outstanding (Basic)	49.7M	49.61M	49.5M	49.43M	49.2M	48.92M
Shares Outstanding (Diluted)	49.7M	49.61M	49.5M	49.43M	49.2M	48.92M
EPS (Basic)	-2.48	-1.5	-1.58	-1.34	-1.14	-0.73
EPS (Diluted)	-2.48	-1.5	-1.58	-1.34	-1.14	-0.73
EBITDA	-121.77M	-73.19M	-77.17M	-65.11M	-55.42M	-34.87M
EBIT	-123.09M	-74.44M	-78.45M	-66.65M	-56.66M	n/a
Depreciation & Amortization	1.32M	1.25M	1.27M	1.21M	850K	633K